- Home
- INDP vs POAI Comparison
INDP vs POAI Comparison
Compare INDP & POAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDP
- POAI
- Stock Information
- Founded
- INDP 2000
- POAI 2002
- Country
- INDP United States
- POAI United States
- Employees
- INDP N/A
- POAI N/A
- Industry
- INDP Biotechnology: Pharmaceutical Preparations
- POAI Industrial Specialties
- Sector
- INDP Health Care
- POAI Health Care
- Exchange
- INDP Nasdaq
- POAI Nasdaq
- Market Cap
- INDP 8.8M
- POAI N/A
- IPO Year
- INDP N/A
- POAI N/A
- Fundamental
- Price
- INDP $0.59
- POAI $1.45
- Analyst Decision
- INDP Strong Buy
- POAI Hold
- Analyst Count
- INDP 2
- POAI 1
- Target Price
- INDP $8.50
- POAI N/A
- AVG Volume (30 Days)
- INDP 1.2M
- POAI 8.1M
- Earning Date
- INDP 03-13-2025
- POAI 05-13-2025
- Dividend Yield
- INDP N/A
- POAI N/A
- EPS Growth
- INDP N/A
- POAI N/A
- EPS
- INDP N/A
- POAI N/A
- Revenue
- INDP N/A
- POAI $1,484,223.00
- Revenue This Year
- INDP N/A
- POAI N/A
- Revenue Next Year
- INDP N/A
- POAI $569.48
- P/E Ratio
- INDP N/A
- POAI N/A
- Revenue Growth
- INDP N/A
- POAI N/A
- 52 Week Low
- INDP $0.58
- POAI $0.55
- 52 Week High
- INDP $3.10
- POAI $3.06
- Technical
- Relative Strength Index (RSI)
- INDP 30.03
- POAI 56.28
- Support Level
- INDP $0.58
- POAI $1.41
- Resistance Level
- INDP $0.78
- POAI $2.60
- Average True Range (ATR)
- INDP 0.14
- POAI 0.17
- MACD
- INDP -0.02
- POAI 0.05
- Stochastic Oscillator
- INDP 0.89
- POAI 27.22
About INDP Indaptus Therapeutics Inc.
Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.